{"id":"W2765414225","doi":"10.1182/blood-2017-09-804641","title":"Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Ibrutinib; Rituximab; Medicine; Follicular lymphoma; Oncology; Refractory (planetary science); Internal medicine; Idelalisib; Phases of clinical research; Clinical trial; Lymphoma; Leukemia; Chronic lymphocytic leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003068795,0.001174839,0.001410967,0.0003167771,0.0004074532,0.001351096,0.0008433082,0.001538869,0.005469467],"category_scores_gemma":[0.001675493,0.0002925241,0.001207096,0.0004724791,0.0008172741,0.0009693003,0.0005097305,0.002846096,0.001477993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283365,"about_ca_system_score_gemma":0.001444821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001013515,"about_ca_topic_score_gemma":0.002552227,"domain_scores_codex":[0.9992645,0.000406369,0.00003052919,0.0001039647,0.00007216931,0.0001224025],"domain_scores_gemma":[0.9990653,0.0001898273,0.000159843,0.0001127454,0.00007700691,0.0003952495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7376468,0.02737816,0.007947723,0.001352138,0.003254291,0.0003295291,0.0003627834,0.002702932,0.01806004,0.0007390884,0.0140782,0.1861484],"study_design_scores_gemma":[0.8421467,0.1333494,0.01108149,0.0001585028,0.0009819228,0.0002905152,0.0001118076,0.001437232,0.001885134,0.0005853979,0.007922715,0.00004928969],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797474,0.006780158,0.0005537475,0.002114288,0.0002676974,0.002624624,0.003096076,0.0001582368,0.004657809],"genre_scores_gemma":[0.9807652,0.002950635,0.001729407,0.002141341,0.0002836387,0.003475506,0.004434772,0.00004941869,0.004170194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005469467,"threshold_uncertainty_score":0.0182972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06832704270368069,"score_gpt":0.3612379891516637,"score_spread":0.292910946447983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}